Fidelity SPDR Advertisement
Home > Boards > US OTC > Miscellaneous >

Seratosa Inc. (STOA)

STOA RSS Feed
Add STOA Price Alert      Hide Sticky   Hide Intro
Moderator: No Moderator
Search This Board:
Last Post: 10/13/2014 11:58:19 AM - Followers: 219 - Board type: Free - Posts Today: 0



Business Description
Sitoa Global Announces Exclusive Letter of Intent With UC San Francisco, New Business Strategy and Corporate Restructuring

HONG KONG, CHINA--(Marketwired - Nov 25, 2013) - Sitoa Global Inc. ("Sitoa Global", or "the Company") (OTCQB: STOA) announced today that it entered into an exclusive letter of intent ("LOI") with the University of California, San Francisco ("UCSF") to negotiate an option agreement in regards to the exclusive global licensing of a medical stereotactic device (the "Device") which the Company believes has the potential to revolutionize the delivery of stem cells into the human brain and enhance the efficacy of a wide range of stem cell therapeutics. Beyond stem cells, the platform technology of the device can also enable the delivery of cellular therapeutics, gene therapies, and traditional drug infusions into the human brain.

The Stem Cell industry is one of the fastest growing and most compelling areas in medicine with numerous companies and research institutions spending hundreds of millions of dollars per year on the development of new therapies and devices. The Company believes that the Device could become the preferred tool for the deployment of stem cells into the human brain for any company or clinician conducting clinical trials and providing experimental treatment in this field. Therefore, the use of the Device could become analogous to the use of 'picks and shovels' during the historical gold rush and allow the Company to pursue such a picks-and-shovels business model and to participate in the growth of the Stem Cell industry as a provider of tools and resources.

The LOI with UCSF and the impending change in business strategy is expected to enable the Company to enter an exciting and high growth industry that is experiencing rapid growth and significant private and public funding opportunities. As a result, the Company is expected to undergo a corporate restructuring in order to enhance shareholder value, to dispose of all its e-commerce and software businesses, and to add industry-relevant expertise to the management team and board.

The Opportunity in the Stem Cell Market

There are numerous companies worldwide that are currently doing research with Regenerative Medicine and Stem Cell technologies. According to the VisionGain Stem Cell Industry Report 2012-2013, the estimated market size for regenerative medicine is $10.7 billion in 2017 ramping up to approx. $22 billion by 2020.

About The Device

Over 9 million patients in the United States suffer from a wide range of neurological disorders including Alzheimer's disease, Parkinson's disease, epilepsy, and multiple sclerosis. Promising stem cell therapies for these disorders are being developed, but most require direct delivery of such cell-based therapeutics to specific brain regions.

Currently available neurosurgical devices can deliver a straight, rigid needle to single brain locations. However, this basic strategy limits the size and "shape" of the brain treatment area. In order to deliver to larger and more complex brain targets, the surgeon needs to penetrate the brain multiple times with such straight needles, which may reduce the efficacy of stem cell therapeutics and increase the risk of bleeding and stroke.

The Device enables the radial deployment of a flexible delivery catheter to large and anatomically complex brain targets through a single initial brain penetration. Thus, the Device allows clinicians to "tailor" therapeutic stem cell delivery to individual patient anatomy and specific disease targets, which may enhance the efficacy of a wide range of stem cell therapies. This modern and "easy to use" platform technology allows "real-time" monitoring of therapeutic delivery under interventional MRI guidance (iMRI), which can improve the accuracy of cell delivery, reduce the risk of complications, and increase patient safety.

To date, the Device has been developed at UCSF with $1.8 million in funding from the California Institute for Regenerative Medicine (CIRM). This initial funding of basic research and development has alleviated much of the early risk associated with developing a new breakthrough technology. It is anticipated that this funding could allow the Device to file for US FDA 510(k) approval by the middle of 2014.

The California Institute for Regenerative Medicine was created by California's Proposition 71 in 2004, which authorized it to issue $3 billion in grants over ten years for embryonic stem cell and other biomedical research. It is believed to be the world's largest single backer of research in stem cells.

UCSF has a patent application filed and pending on the intellectual property of the Device.

About UCSF

The University of California, San Francisco (UCSF) is a leading university dedicated to promoting health worldwide through advanced biomedical research, graduate-level education in the life sciences and health professions, and excellence in patient care. UCSF is the nation's top public recipient of funding from the National Institutes of Health (NIH), in research and education in such areas as cancer, cardiovascular disease, diabetes, infectious diseases, neurology and stem cells. UCSF and each of its schools have ranked among the top four in NIH funding for more than a decade, reflecting the caliber of research and education being performed at the University.

         SEC Filings(STOA)
            
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
STOA
Current Price
Volume:
Bid Ask Day's Range
Wiki
STOA News: Amended Statement of Ownership (sc 13g/a) 09/08/2014 04:09:50 PM
STOA News: Quarterly Report (10-q) 08/12/2014 02:12:46 PM
STOA News: Statement of Ownership (sc 13g) 08/08/2014 03:50:24 PM
STOA News: Current Report Filing (8-k) 06/20/2014 02:46:38 PM
STOA News: Current Report Filing (8-k) 05/21/2014 02:14:04 PM
PostSubject
#12149  Sticky Note Please stay on topic. The only topic to IH Admin [Dan] 06/22/13 03:54:48 PM
#24316   Maybe Hereitfirst 10/13/14 11:58:19 AM
#24315   This gunna move soon? skaman069 10/12/14 10:08:43 PM
#24314   I am I bought those 320s at 24 Hereitfirst 10/11/14 07:19:56 AM
#24313   LOL Looks like BS to me. WarMachine 10/11/14 07:18:37 AM
#24312   No I appreciate theirs http://profit.ly/1MpebE?aff=4534 Hereitfirst 10/11/14 07:12:59 AM
#24311   The managements home mortgage holders appreciate your donation. WarMachine 10/11/14 07:10:54 AM
#24310   .........loading Hereitfirst 10/10/14 10:31:39 PM
#24309   For some reason I don't trust anything that phinehas 08/12/14 08:42:38 PM
#24308   Seen Friday's filing mannken 08/10/14 11:03:21 PM
#24307   It would be good for a lot if phinehas 08/09/14 11:27:26 AM
#24306   I have some shares stuck in this thing. hyrpowr 08/08/14 10:56:31 PM
#24305   Knight Capital got handed 59,461 shares with voting power WarMachine 08/08/14 09:39:23 PM
#24304   Does anyone no what this news mean? phinehas 08/08/14 05:42:57 PM
#24303   Slack from noteholders always a good sign and 12yearplan 06/22/14 10:57:38 AM
#24302   STOA..that would be interesting to hear...definately a bagholder 1ray 06/22/14 10:45:39 AM
#24301   Yes, Something Anything. Stoa has left not a 12yearplan 06/22/14 10:35:06 AM
#24300   Sounds to me a reasonable assumption, but hopefully 1ray 06/22/14 09:59:49 AM
#24299   Lol my average is 18.7$ pikhenry 06/22/14 02:44:59 AM
#24298   My initial thought was it's simply the "fee" 12yearplan 06/21/14 09:00:28 AM
#24297   STOA NEWS OUT !!!!!! 1ray 06/21/14 07:55:42 AM
#24296   would that make the pps 1.16 at that 1ray 06/21/14 07:54:01 AM
#24295   ITEM 1.01 ENTRY INTO A MATERIAL DEFINITIVE AGREEMENT 12yearplan 06/20/14 03:15:46 PM
#24294   lost all of my investment in this scam! pikhenry 05/31/14 10:18:37 PM
#24293   Stoa is dead. Ceo is a liar! rusure2013 05/30/14 06:20:44 AM
#24292   10 Billion authorized shares. He can turn on space1230 05/28/14 10:47:10 AM
#24291   This ceo should be put in jail for scamming. dragon2009 05/28/14 07:24:47 AM
#24290   NEWS OUT trender18 05/21/14 05:21:22 PM
#24289   Jep... Think I must agree. Lost really a goodyboy 05/15/14 11:55:27 AM
#24288   Absolutely nothing. A horrible investment by all Stockhunter22 05/15/14 11:51:57 AM
#24287   What's going on? goodyboy 05/15/14 11:11:52 AM
#24286   Their turnover jumped again.Just a small loss this modes948 05/13/14 09:22:01 PM
#24285   Found it. James Wang hayn 05/13/14 12:51:55 PM
#24284   Does anyone remember Wang's full name. I'm hayn 05/13/14 10:31:54 AM
#24283   I will take 2 shares of stoa lol. Stockhunter22 05/03/14 02:07:10 PM
#24282   lmao StockWizard 04/27/14 08:57:32 PM
#24281   Scam scam scam! phinehas 04/24/14 03:11:08 PM
#24280   Hmmm do you work for this new management Stockhunter22 04/20/14 11:19:34 AM
#24279   Sounds like every other stinky pinky scam. Wang WarMachine 04/10/14 08:52:11 AM
#24278   Hearing that Wang is on the way out Ixtlan 04/10/14 07:14:30 AM
#24277   Another one... skaman069 04/08/14 11:50:38 AM
#24276   Someone who Needs money and sells with serious goodyboy 04/04/14 12:47:48 PM
#24275   Random... volume today??? skaman069 04/04/14 10:19:57 AM
#24274   wow...anybody reported these guys to SEC yet?? sandtrap246 03/29/14 02:18:16 AM
#24273   Lol, go! 12yearplan 03/18/14 03:22:25 PM
#24272   Possibly disposable umbrellas. Or maybe the device Stockhunter22 03/18/14 03:19:01 PM
#24271   STOA get into poultry farming? 12yearplan 03/18/14 02:29:50 PM
#24270   Yes but then I would have even less chetntam 03/13/14 08:14:00 AM
#24269   maybe after an other RS ... Anonymous777 03/12/14 11:53:30 PM
#24268   Again 500 shares bought @ ask.... 0,75 Perhaps goodyboy 03/12/14 11:27:34 AM
#24267   Who would ever do that??? skaman069 03/11/14 05:47:39 PM
PostSubject